Junctional adhesion molecules in cerebral endothelial tight junction and brain metastasis

Anticancer Research

Volumn 33, Issue 6, 2013, Pages 2353-2359

  Jia, Wang ^a   Martin, Tracey A ^b   Zhang, Guobin ^a   Jiang, Wen G ^b  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Brain metastasis blood brain barrier (BBB); Junctional adhesion molecules (JAMs); Review; Tight junctions (TJs)

Indexed keywords

CASEIN KINASE II; CELL ADHESION MOLECULE; CYCLIC AMP DEPENDENT PROTEIN KINASE; ENDOTHELIAL CELL SELECTIVE ADHESION MOLECULE; JUNCTIONAL ADHESION MOLECULE; MEMBRANE PROTEIN; PROTEIN KINASE B; PROTEIN KINASE C; UNCLASSIFIED DRUG;

ASTROCYTE; BASEMENT MEMBRANE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN METASTASIS; BRAIN TISSUE; BREAST CANCER; CANCER CELL; CELL STRUCTURE; DENDRITIC CELL; DISULFIDE BOND; ENDOTHELIUM CELL; HUMAN; LUNG CANCER; MELANOMA; MICROVASCULAR ENDOTHELIAL CELL; NATURAL KILLER CELL; NONHUMAN; PERICYTE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; TIGHT JUNCTION; TUMOR MICROENVIRONMENT; ANIMAL; BRAIN; BRAIN METASTASIS BLOOD-BRAIN BARRIER (BBB); BRAIN TUMOR; CHEMISTRY; JUNCTIONAL ADHESION MOLECULES (JAMS); METABOLISM; METASTASIS; PROTEIN TERTIARY STRUCTURE; TIGHT JUNCTIONS (TJS); TRANSPORT AT THE CELLULAR LEVEL; ULTRASTRUCTURE; VASCULARIZATION;

BRAIN METASTASIS BLOOD-BRAIN BARRIER (BBB); JUNCTIONAL ADHESION MOLECULES (JAMS); REVIEW; TIGHT JUNCTIONS (TJS);

ANIMALS; BIOLOGICAL TRANSPORT; BLOOD-BRAIN BARRIER; BRAIN; BRAIN NEOPLASMS; ENDOTHELIAL CELLS; HUMANS; JUNCTIONAL ADHESION MOLECULES; PROTEIN STRUCTURE, TERTIARY; SIGNAL TRANSDUCTION; TIGHT JUNCTIONS;

MLCS; MLOWN;

EID: 84881332287     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Wilhelm I, Molnar J, Fazakas C, Hasko J and Krizbai IA: Role of the blood-brain barrier in the formation of brain metastasis. Int J Mol Sci 14: 1383-1411, 2013.
2. Meert AP, Paesmans M, Berghmans T, Martin B, Mascaux C, Vallot F, Verdebout JM, Lafitte JJ and Sculier JP: Prophylactic cranial irradiation in small cell lung cancer: a systematic review of the literature with meta-Analysis. BMC Cancer 1: 5, 2001.
3. Slotman B, Faivre-Finn C, Kramer G, Rankin E, Snee M, Hatton M, Postmus P, Collette L, Musat E and Senan S: Prophylactic cranial irradiation in extensive small-cell lung cancer. N Engl J Med 357: 664-672, 2007.
4. Talmadge JE and Fidler IJ: AACR centennial series: the biology of cancer metastasis: historical perspective. Cancer Res 70: 5649-5669, 2010.
5. Fidler IJ, Yano S, Zhang RD, Fujimaki T and Bucana CD: The seed and soil hypothesis: Vascularisation and brain metastasis. Lancet Oncol 3: 53-57, 2002.
6. Wu W, Murata J, Hayashi K, Yamaura T, Mitani N and Saiki I: Social isolation stress impairs the resistance of mice to experimental liver metastasis of murine colon 26-L5 carcinoma cells. Biol Pharm Bull 24: 772-776, 2001.
7. Theoharides TC and Kalogeromitros D: The critical role of mast cells in allergy and inflammation. Ann NY Acad Sci 1088: 78-99, 2006.
8. Brabletz S, Schmalhofer O and Brabletz T: Gastrointestinal stem cells in development and cancer. J Pathol 217: 307-317, 2009.
9. Balda MS and Matter K: Tight junctions and the regulation of gene expression. Biochim Biophys Acta 1788: 761-767, 2009.
10. Kniesel U and Wolburg H: Tight junctions of the blood-brain barrier. Cell Mol Neurobiol 20: 57-76, 2000.
11. Huber JD, Egleton RD and Davis T P: Molecular physiology and pathophysiology of tight junctions in the blood-brain barrier. Trends Neurosci 24: 719-725, 2001.
12. McSherry EA, McGee SF, Jirstrom K, Doyle EM, Brennan DJ, Landberg G, Dervan PA, Hopkins AM and Gallagher WM: JAMA expression positively correlates with poor prognosis in breast cancer patients. Int J Cancer 125: 1343-1351, 2009.
13. Naik MU, Naik TU, Suckow AT, Duncan MK and Naik UP: Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 68: 2194-2203, 2008.
14. Imhof BA and Aurrand-Lions M: Adhesion mechanisms regulating the migration of monocytes. Nat Rev Immunol 4: 432-444, 2004.
15. Palmeri D, van Zante A, Huang CC, Hemmerich S and Rosen SD: Vascular endothelial junction-Associated molecule, a novel member of the immunoglobulin superfamily, is localized to intercellular boundaries of endothelial cells. J Biol Chem 275: 19139-19145, 2000.
16. Liang TW, Chiu HH, Gurney A, Sidle A, Tumas DB, Schow P, Foster J, Klassen T, Dennis K, DeMarco RA, Pham T, Frantz G and Fong S: Vascular endothelial-junctional adhesion molecule (VE-JAM)/JAM 2 interacts with T, NK, and dendritic cells through JAM3. J Immunol 168: 1618-1626, 2002.
17. Hirabayashi S, Tajima M, Yao I, Nishimura W, Mori H and Hata Y: JAM4, a junctional cell adhesion molecule interacting with a tight junction protein, MAGI-1. Mol Cell Biol 23: 4267-4282, 2003.
18. Moog-Lutz C, Cave-Riant F, Guibal FC, Breau MA, Di Gioia Y, Couraud PO, Cayre YE, Bourdoulous S and Lutz PG: JAML, a novel protein with characteristics of a junctional adhesion molecule, is induced during differentiation of myeloid leukemia cells. Blood 102: 3371-3378, 2003.
19. Wegmann F, Petri B, Khandoga AG, Moser C, Khandoga A, Volkery S, Li H, Nasdala I, Brandau O, Fassler R, Butz S, Krombach F and Vestweber D: ESAM supports neutrophil extravasation, activation of Rho, and VEGF-induced vascular permeability. J Exp Med 203: 1671-1677, 2006.
20. Cohen CJ, Shieh JT, Pickles RJ, Okegawa T, Hsieh JT and Bergelson JM: The coxsackievirus and adenovirus receptor is a transmembrane component of the tight junction. Proc Natl Acad Sci USA 98: 15191-15196, 2001.
21. Bazzoni G: The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 15: 525-530, 2003.
22. Arrate MP, Rodriguez JM, Tran TM, Brock TA and Cunningham SA: Cloning of human junctional adhesion molecule 3 (JAM3) and its identification as the JAM2 counter-receptor. J Biol Chem 276: 45826-45832, 2001.
23. Prota AE, Campbell JA, Schelling P, Forrest JC, Watson MJ, Peters TR, Aurrand-Lions M, Imhof BA, Dermody TS and Stehle T: Crystal structure of human junctional adhesion molecule 1: implications for reovirus binding. Proc Natl Acad Sci USA 100: 5366-5371, 2003.
24. Mandell K J and Parkos C A: The JAM family of proteins. Adv Drug Deliv Rev 57: 857-867, 2005.
25. Weber C, Fraemohs L and Dejana E: The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7: 467-477, 2007.
26. Cunningham SA, Arrate MP, Rodriguez JM, Bjercke RJ, Vanderslice P, Morris AP and Brock TA: A novel protein with homology to the junctional adhesion molecule. Characterization of leukocyte interactions. J Biol Chem 275: 34750-34756, 2000.
27. Naik UP, Naik MU, Eckfeld K, Martin-DeLeon P and Spychala J: Characterization and chromosomal localization of JAM-1, a platelet receptor for a stimulatory monoclonal antibody. J Cell Sci 114: 539-547, 2001.
28. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M and Parkos CA: JAM-C regulates tight junctions and integrinmediated cell adhesion and migration. J Biol Chem 282: 1830-1837, 2007.
29. Liu Y, Nusrat A, Schnell FJ, Reaves TA, Walsh S, Pochet M and Parkos CA: Human junction adhesion molecule regulates tight junction resealing in epithelia. J Cell Sci 113: 2363-2374, 2000.
30. Ebnet K, Suzuki A, Horikoshi Y, Hirose T, Meyer Zu Brickwedde MK, Ohno S and Vestweber D: The cell polarity protein ASIP/PAR-3 directly associates with junctional adhesion molecule (JAM). EMBO J 20: 3738-3748, 2001.
31. Del Maschio A, De Luigi A, Martin-Padura I, Brockhaus M, Bartfai T, Fruscella P, Adorini L, Martino G, Furlan R, De Simoni MG and Dejana E: Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM). J Exp Med 190: 1351-1356, 1999.
32. Ebnet K, Aurrand-Lions M, Kuhn A, Kiefer F, Butz S, Zander K, Meyer zu Brickwedde MK, Suzuki A, Imhof BA and Vestweber D: The junctional adhesion molecule (JAM) family members JAM-2 and JAM-3 associate with the cell polarity protein PAR-3: A possible role for JAMs in endothelial cell polarity. J Cell Sci 116: 3879-3891, 2003.
33. Kostrewa D, Brockhaus M, D'Arcy A, Dale GE, Nelboeck P, Schmid G, Mueller F, Bazzoni G, Dejana E, Bartfai T, Winkler FK and Hennig M: X-Ray structure of junctional adhesion molecule: structural basis for homophilic adhesion via a novel dimerization motif. EMBO J 20: 4391-4398, 2001.
34. Bazzoni G, Martinez-Estrada OM, Mueller F, Nelboeck P, Schmid G, Bartfai T, Dejana E and Brockhaus M: Homophilic interaction of junctional adhesion molecule. J Biol Chem 275: 30970-30976, 2000.
35. Babinska A, Kedees MH, Athar H, Ahmed T, Batuman O, Ehrlich YH, Hussain MM and Kornecki E: F11-receptor (F11R/JAM) mediates platelet adhesion to endothelial cells: Role in inflammatory thrombosis. Thromb Haemost 88: 843-850, 2002.
36. Santoso S, Orlova VV, Song K, Sachs UJ, Andrei-Selmer CL and Chavakis T: The homophilic binding of junctional adhesion molecule-C mediates tumor cell-endothelial cell interactions. J Biol Chem 280: 36326-36333, 2005.
37. Mandell K J, Mccall I C, Parkos C A: Involvement of the junctional adhesion molecule-1 (JAM1) homodimer interface in regulation of epithelial barrier function. J Biol Chem 279: 16254-16262, 2004.
38. Bazzoni G: Endothelial tight junctions: Permeable barriers of the vessel wall. Thromb Haemost 95: 36-42, 2006.
39. Cunningham SA, Rodriguez JM, Arrate MP, Tran TM and Brock TA: JAM2 interacts with α4β1. Facilitation by JAM3. J Biol Chem 277: 27589-27592, 2002.
40. Lamagna C, Meda P, Mandicourt G, Brown J, Gilbert RJ, Jones EY, Kiefer F, Ruga P, Imhof BA and Aurrand-Lions M: Dual interaction of JAM-C with JAM-B and α(M)β2 integrin: Function in junctional complexes and leukocyte adhesion. Mol Biol Cell 16: 4992-5003, 2005.
41. Ostermann G, Weber KS, Zernecke A, Schroder A and Weber C: JAM-1 is a ligand of the beta(2) integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 3: 151-158, 2002.
42. Ludwig RJ, Hardt K, Hatting M, Bistrian R, Diehl S, Radeke HH, Podda M, Schon MP, Kaufmann R, Henschler R, Pfeilschifter JM, Santoso S and Boehncke WH: Junctional adhesion molecule (JAM)-B supports lymphocyte rolling and adhesion through interaction with α4β1 integrin. Immunology 128: 196-205, 2009.
43. Santoso S, Sachs UJ, Kroll H, Linder M, Ruf A, Preissner KT and Chavakis T: The junctional adhesion molecule 3 (JAM-3) on human platelets is a counter receptor for the leukocyte integrin Mac-1. J Exp Med 196: 679-691, 2002.
44. Martinez-Estrada OM, Villa A, Breviario F, Orsenigo F, Dejana E and Bazzoni G: Association of junctional adhesion molecule with calcium/calmodulin- dependent serine protein kinase (CASK/LIN-2) in human epithelial CACO-2 cells. J Biol Chem 276: 9291-9296, 2001.
45. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG and Vestweber D: Involvement of nectin in the localization of junctional adhesion molecule at tight junctions. Oncogene 21: 7642-7655, 2002.
46. Ebnet K, Schulz CU, Meyer Zu Brickwedde MK, Pendl GG and Vestweber D: Junctional adhesion molecule interacts with the PDZ domain-containing proteins AF-6 and ZO-1. J Biol Chem 275: 27979-27988, 2000.
47. Hamazaki Y, Itoh M, Sasaki H, Furuse M and Tsukita S: Multi-PDZ domain protein 1 (MUPP1) is concentrated at tight junctions through its possible interaction with claudin-1 and junctional adhesion molecule. J Biol Chem 277: 455-461, 2002.
48. Fanning AS, Ma TY and Anderson J M: Isolation and functional characterization of the actin binding region in the tight junction protein ZO-1. FASEB J 16: 1835-1837, 2002.
49. Naik MU, Naik TU, Suckow AT, Duncan MK and Naik UP: Attenuation of junctional adhesion molecule-A is a contributing factor for breast cancer cell invasion. Cancer Res 68: 2194-2203, 2008.
50. Gutwein P, Schramme A, Voss B, Abdel-Bakky MS, Doberstein K, Ludwig A, Altevogt P, Hansmann ML, Moch H, Kristiansen G and Pfeilschifter J: Down-regulation of junctional adhesion molecule-A is involved in the progression of clear cell renal cell carcinoma. Biochem Biophys Res Commun 380: 387-391, 2009.
51. Martin TA, Watkins G, Mansel RE, Jiang WG: Hepatocyte growth factor disrupts tight junctions in human breast cancer cells. Cell Biol Int 28: 361-371, 2004.
52. Martin-Padura I, Lostaglio S, Schneemann M, Williams L, Romano M, Fruscella P, Panzeri C, Stoppacciaro A, Ruco L, Villa A, Simmons D and Dejana E: Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol 142: 117-127, 1998.
53. Haarmann A, Deiss A, Prochaska J, Foerch C, Weksler B, Romero I, Couraud PO, Stoll G, Rieckmann P and Buttmann M: Evaluation of soluble junctional adhesion molecule-A as a biomarker of human brain endothelial barrier breakdown. PLoS One 5: e13568, 2010.
54. Yeung D, Manias JL, Stewart DJ and Nag S: Decreased junctional adhesion molecule-A expression during blood-brain barrier breakdown. Acta Neuropathol 115: 635-642, 2008.
55. Dejana E: The transcellular railway: Insights into leukocyte diapedesis. Nat Cell Biol 8: 105-107, 2006.
56. Carman CV: Mechanisms for transcellular diapedesis: Probing and pathfinding by 'invadosome-like protrusions'. J Cell Sci 122: 3025-3035, 2009.
57. Fazakas C, Wilhelm I, Nagyoszi P, Farkas AE, Hasko J, Molnar J, Bauer H, Bauer HC, Ayaydin F, Dung NT, Siklos L and Krizbai IA: Transmigration of melanoma cells through the blood-brain barrier: Role of endothelial tight junctions and melanoma-released serine proteases. PLoS One 6: e20758, 2011.
58. Khuon S, Liang L, Dettman RW, Sporn PH, Wysolmerski RB and Chew TL: Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: A three-dimensional FRET study. J Cell Sci 123: 431-440, 2010.
59. Weber C, Fraemohs L and Dejana E: The role of junctional adhesion molecules in vascular inflammation. Nat Rev Immunol 7: 467-477, 2007.
60. Malergue F, Galland F, Martin F, Mansuelle P, Aurrand-Lions M and Naquet P: A novel immunoglobulin superfamily junctional molecule expressed by antigen presenting cells. endothelial cells and platelets, Mol Immunol 35: 1111-1119, 1998.
61. Williams LA, Martin-Padura I, Dejana E, Hogg N and Simmons DL: Identification and characterisation of human junctional adhesion molecule (JAM). Mol Immunol 36: 1175-1188, 1999.
62. Aurrand-Lions MA, Duncan L, Du Pasquier L and Imhof BA: Cloning of JAM-2 and JAM-3: An emerging junctional adhesion molecular family? Curr Top Microbiol Immunol 251: 91-98, 2000.
63. Aurrand-Lions M, Duncan L, Ballestrem C and Imhof BA: A novel immunoglobulin superfamily molecule, expressed by endothelial and lymphatic cells. J Biol Chem 276: 2733-2741, 2001.
64. Weksler B, Romero IA and Couraud PO: The hCMEC/D3 cell line as a model of the human blood brain barrier. Fluids Barriers CNS 10: 16, 2013.
65. Schrade A, Sade H, Couraud PO, Romero IA, Weksler BB and Niewoehner J: Expression and localization of claudins-3 and -12 in transformed human brain endothelium. Fluids Barriers CNS 9: 6, 2012.